What Are Oral MS Treatments?

Oral MS treatments are prescription medications taken by mouth that help manage multiple sclerosis symptoms and modify disease progression. These medications represent a significant advancement in MS care, as they eliminate the need for injections or infusions that were previously the only treatment options available.

These medications work in different ways to reduce inflammation in the central nervous system and prevent the immune system from attacking the protective covering of nerve fibers. Depending on the specific medication, they may be taken once or twice daily, making them convenient to incorporate into your regular routine. Most oral treatments are approved for relapsing forms of MS, including relapsing-remitting MS (RRMS) and active secondary progressive MS (SPMS).

How Oral MS Medications Work

Oral MS treatments operate through several mechanisms to reduce disease activity. Some medications prevent immune cells from leaving the lymph nodes, reducing the number of potentially harmful cells that can enter the central nervous system. Others target specific enzymes or receptors involved in the inflammatory process.

For example, some oral medications work by binding to specific proteins on the surface of immune cells, preventing them from crossing the blood-brain barrier. Others may inhibit enzymes that play a role in the activation of immune cells. By interfering with these processes, oral MS medications can reduce the frequency and severity of relapses, slow disability progression, and limit the formation of new lesions in the brain and spinal cord as shown on MRI scans.

Comparing Oral MS Treatment Providers

Several pharmaceutical companies offer FDA-approved oral medications for MS treatment, each with unique benefits and considerations:

Novartis produces fingolimod (Gilenya), one of the first oral MS treatments approved. It's taken once daily and works by trapping certain immune cells in lymph nodes.

Biogen offers dimethyl fumarate (Tecfidera), which reduces inflammation through activation of antioxidant pathways. It's taken twice daily with food.

Sanofi provides teriflunomide (Aubagio), a once-daily medication that inhibits rapidly dividing cells like those in the immune system that cause inflammation.

Bristol Myers Squibb markets ozanimod (Zeposia), a newer once-daily option that modulates specific receptors to prevent lymphocytes from leaving lymph nodes.

Janssen produces ponesimod (Ponvory), another selective receptor modulator taken once daily.

Benefits and Limitations of Oral Treatments

The advantages of oral MS treatments include convenience, elimination of injection-related side effects, and improved adherence for many patients. Taking a pill is generally more comfortable than self-administering injections, which can lead to better long-term treatment compliance.

However, oral treatments come with their own considerations. Some require more frequent monitoring, including blood tests to check liver function or heart monitoring. Side effects vary by medication but may include gastrointestinal issues, flushing, headaches, or hair thinning. Some medications also carry risks of more serious side effects like infections or liver problems.

Roche, which offers both injectable and oral options through its subsidiaries, notes on their website that treatment decisions should balance efficacy, safety, and lifestyle factors. Similarly, Merck KGaA (operating as EMD Serono in North America) emphasizes the importance of personalized treatment approaches.

Cost and Insurance Considerations

Oral MS medications typically cost between $60,000-$95,000 per year without insurance coverage. Most patients rely on insurance, manufacturer assistance programs, or both to make these treatments affordable.

Insurance coverage varies widely. Many plans require prior authorization, step therapy (trying less expensive treatments first), or specialty pharmacy distribution. Patient assistance programs from companies like Genentech, a member of the Roche Group, can help eligible patients access medications at reduced costs.

Patient advocacy organizations like the National MS Society provide resources to help navigate insurance and financial assistance options. They can connect patients with programs that may help cover costs of medications, including those from Novartis, Biogen, and other manufacturers.

When evaluating cost, consider not just the medication price but also monitoring requirements. Some treatments require more frequent lab work or imaging, adding to the overall expense. Discussing these factors with your healthcare provider and insurance company can help determine the most cost-effective approach for your situation.

Conclusion

Oral MS treatments have transformed the management of multiple sclerosis by offering effective options without the burden of injections. When choosing a treatment, work closely with your healthcare provider to find the option that best addresses your specific form of MS, lifestyle needs, and health considerations. Regular monitoring and open communication about side effects are essential parts of successful treatment.

Remember that what works best varies from person to person. Some patients may respond better to traditional injectable therapies or newer infusion treatments available from companies like AbbVie. The good news is that with multiple oral options now available, you have more choices than ever to help manage your MS while maintaining quality of life.

Citations

This content was written by AI and reviewed by a human for quality and compliance.